These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 9169725

  • 1. Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicity.
    Lucas R, Echtenacher B, Sablon E, Juillard P, Magez S, Lou J, Donati Y, Bosman F, Van de Voorde A, Fransen L, Männel DN, Grau GE, de Baetselier P.
    Infect Immun; 1997 Jun; 65(6):2006-10. PubMed ID: 9169725
    [Abstract] [Full Text] [Related]

  • 2. Lectin-deficient TNF mutants display comparable anti-tumour but reduced pro-metastatic potential as compared to the wild-type molecule.
    Lucas R, Montesano R, Pepper MS, Hafner M, Sablon E, Dunant Y, Grau GE, De Baetselier P, Männel D, Fransen L.
    Int J Cancer; 2001 Feb 15; 91(4):543-9. PubMed ID: 11251979
    [Abstract] [Full Text] [Related]

  • 3. Identification of tumor necrosis factor (TNF) amino acids crucial for binding to the murine p75 TNF receptor and construction of receptor-selective mutants.
    Ameloot P, Fiers W, De Bleser P, Ware CF, Vandenabeele P, Brouckaert P.
    J Biol Chem; 2001 Oct 05; 276(40):37426-30. PubMed ID: 11448951
    [Abstract] [Full Text] [Related]

  • 4. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice.
    Ameloot P, Takahashi N, Everaerdt B, Hostens J, Eugster HP, Fiers W, Brouckaert P.
    Eur J Immunol; 2002 Oct 05; 32(10):2759-65. PubMed ID: 12355427
    [Abstract] [Full Text] [Related]

  • 5. Functional identification of the alveolar edema reabsorption activity of murine tumor necrosis factor-alpha.
    Elia N, Tapponnier M, Matthay MA, Hamacher J, Pache JC, Brundler MA, Totsch M, De Baetselier P, Fransen L, Fukuda N, Morel DR, Lucas R.
    Am J Respir Crit Care Med; 2003 Nov 01; 168(9):1043-50. PubMed ID: 12842853
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.
    Amar S, Van Dyke TE, Eugster HP, Schultze N, Koebel P, Bluethmann H.
    J Inflamm; 2003 Nov 01; 47(4):180-9. PubMed ID: 9144075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased expression of functionally active membrane-associated tumor necrosis factor in acute respiratory distress syndrome.
    Armstrong L, Thickett DR, Christie SJ, Kendall H, Millar AB.
    Am J Respir Cell Mol Biol; 2000 Jan 01; 22(1):68-74. PubMed ID: 10615067
    [Abstract] [Full Text] [Related]

  • 11. Membrane TNF-alpha-activated programmed necrosis is mediated by Ceramide-induced reactive oxygen species.
    Ardestani S, Deskins DL, Young PP.
    J Mol Signal; 2013 Nov 01; 8(1):12. PubMed ID: 24180579
    [Abstract] [Full Text] [Related]

  • 12. Optimal site-specific PEGylation of mutant TNF-alpha improves its antitumor potency.
    Yoshioka Y, Tsutsumi Y, Ikemizu S, Yamamoto Y, Shibata H, Nishibata T, Mukai Y, Okamoto T, Taniai M, Kawamura M, Abe Y, Nakagawa S, Nagata S, Yamagata Y, Mayumi T.
    Biochem Biophys Res Commun; 2004 Mar 19; 315(4):808-14. PubMed ID: 14985084
    [Abstract] [Full Text] [Related]

  • 13. Interaction between transmembrane TNF and TNFR1/2 mediates the activation of monocytes by contact with T cells.
    Rossol M, Meusch U, Pierer M, Kaltenhäuser S, Häntzschel H, Hauschildt S, Wagner U.
    J Immunol; 2007 Sep 15; 179(6):4239-48. PubMed ID: 17785864
    [Abstract] [Full Text] [Related]

  • 14. Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro.
    Yamaguchi M, Murakami T, Tomimatsu T, Nishio Y, Mitsuda N, Kanzaki T, Kurachi H, Shima K, Aono T, Murata Y.
    Biochem Biophys Res Commun; 1998 Mar 06; 244(1):30-4. PubMed ID: 9514868
    [Abstract] [Full Text] [Related]

  • 15. Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window.
    Shibata H, Yoshioka Y, Ikemizu S, Kobayashi K, Yamamoto Y, Mukai Y, Okamoto T, Taniai M, Kawamura M, Abe Y, Nakagawa S, Hayakawa T, Nagata S, Yamagata Y, Mayumi T, Kamada H, Tsutsumi Y.
    Clin Cancer Res; 2004 Dec 15; 10(24):8293-300. PubMed ID: 15623605
    [Abstract] [Full Text] [Related]

  • 16. Expression of an exogenous tumor necrosis factor (TNF) gene in TNF-sensitive cell lines confers resistance to TNF-mediated cell lysis.
    Vanhaesebroeck B, Decoster E, Van Ostade X, Van Bladel S, Lenaerts A, Van Roy F, Fiers W.
    J Immunol; 1992 May 01; 148(9):2785-94. PubMed ID: 1374099
    [Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
    Kondo S, Sauder DN.
    Eur J Immunol; 1997 Jul 01; 27(7):1713-8. PubMed ID: 9247582
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.